Conduct of phase i trials. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Leukocytes, Mononuclear Bone Marrow Mouth Mucosa

Organisms2

Coxiella Adenoviridae

Diseases60

Neoplasms Nausea Neutropenia Thrombocytopenia Vomiting Hematologic Diseases Leukopenia Lung Neoplasms Stomatitis Melanoma Fatigue Neoplasm Metastasis Neoplasm Recurrence, Local Brain Stem Neoplasms Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung Kidney Neoplasms Brain Neoplasms Drug-Related Side Effects and Adverse Reactions Carcinoma, Renal Cell Recurrence Peritoneal Neoplasms Glioma Breast Neoplasms Exanthema Adenocarcinoma Headache Diarrhea Colorectal Neoplasms Fever Drug Eruptions Cheilitis Sarcoma Gastrointestinal Neoplasms Lymphoma, Non-Hodgkin Head and Neck Neoplasms Disease Progression Agranulocytosis Pancreatic Neoplasms Anorexia Mixed Tumor, Mesodermal Glioblastoma Neurofibroma, Plexiform Fallopian Tube Neoplasms Skin Neoplasms Prostatic Neoplasms Skin Diseases Drug Hypersensitivity Meningeal Neoplasms Central Nervous System Neoplasms Leukemia Nervous System Diseases Lymphoma Leukemia, B-Cell Carcinoma, Squamous Cell Liver Neoplasms Hypotension Rectal Neoplasms Anemia Pain

Chemicals and Drugs87

Antineoplastic Agents Paclitaxel Deoxycytidine Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Carboplatin Fluorouracil Antibodies, Monoclonal Camptothecin Dacarbazine Taxoids Cisplatin Topotecan Quinazolines Cancer Vaccines Immunotoxins Drugs, Investigational Recombinant Proteins Doxorubicin Benzenesulfonates Pyrazines Antineoplastic Agents, Alkylating Boronic Acids Organoplatinum Compounds Placebos Phenylurea Compounds Farnesyltranstransferase Epothilones Pyridines Niacinamide Yttrium Radioisotopes Aziridines Nitrogen Mustard Compounds Guanine Vinblastine Granulocyte Colony-Stimulating Factor Etoposide Leucovorin Aminopterin Interleukin-2 Antibodies, Monoclonal, Humanized Protein Kinase Inhibitors Prodrugs Vaccines, Subunit Cyclophosphamide Antibiotics, Antineoplastic Piperidines Angiogenesis Inhibitors Bryostatins Radiation-Sensitizing Agents Diphenhydramine Benzoquinones Pyrimidines Hydroxamic Acids Oxonic Acid Quinolines Carmustine Phthalazines Depsipeptides Thiophenes Enzyme Inhibitors Iodine Radioisotopes Sirolimus Granulocyte-Macrophage Colony-Stimulating Factor Pyrroles Ricin Tegafur Interferon-alpha Drug Combinations Amifostine Lactones Antigens, Neoplasm AIDS Vaccines Triazines MART-1 Antigen Lactams, Macrocyclic Hexanones Melphalan Quinolones Alkyl and Aryl Transferases Cytarabine Antibodies, Neoplasm Sulfonamides Adjuvants, Immunologic gp100 Melanoma Antigen Indoles Benzamides

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Clinical Trials, Phase I as Topic Maximum Tolerated Dose Drug Evaluation Drug Administration Schedule Clinical Trials as Topic Infusions, Intravenous Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Nontherapeutic Human Experimentation Area Under Curve Administration, Oral Research Design Clinical Trials, Phase II as Topic Combined Modality Therapy Metabolic Clearance Rate Clinical Trials, Phase III as Topic Feasibility Studies Patient Selection Double-Blind Method Injections, Subcutaneous Follow-Up Studies Neoplasm Staging Infusions, Parenteral Radioimmunotherapy Therapeutic Human Experimentation Survival Analysis Survival Rate Injections, Intravenous Placebos Multicenter Studies as Topic Drug Therapy, Combination Disease-Free Survival Radiotherapy Dosage Dose Fractionation Cohort Studies Pilot Projects Controlled Clinical Trials as Topic Immunotherapy Hemibody Irradiation Prospective Studies Genetic Therapy Chemoradiotherapy Clinical Protocols Risk Assessment Molecular Targeted Therapy Questionnaires Endpoint Determination Platelet Count Prognosis Salvage Therapy Remission Induction Dose-Response Relationship, Radiation Drug Evaluation, Preclinical Single-Blind Method Infusion Pumps Leukocyte Count Radiotherapy, Conformal Injections, Intralesional Treatment Failure Transplantation, Autologous Blood Cell Count Early Termination of Clinical Trials Sample Size Administration, Intravesical Drug Delivery Systems Kaplan-Meier Estimate Vaccination Infusions, Intra-Arterial Retrospective Studies Karnofsky Performance Status Leukapheresis Risk Factors Immunotherapy, Adoptive Severity of Illness Index

Psychiatry and Psychology7

Conduct Disorder Truth Disclosure Personal Autonomy Disclosure Antisocial Personality Disorder Comprehension Pain

Phenomena and Processes18

Maximum Tolerated Dose Dose-Response Relationship, Drug Area Under Curve Metabolic Clearance Rate Time Factors Half-Life Metabolic Detoxication, Phase I Drug Resistance, Neoplasm Tissue Distribution Platelet Count Dose-Response Relationship, Radiation Biological Availability Leukocyte Count Blood Cell Count Drug Interactions Drug Synergism Genetic Vectors Pain

Disciplines and Occupations5

Nontherapeutic Human Experimentation Research Design Therapeutic Human Experimentation Medical Oncology Biomedical Research

Anthropology, Education, Sociology and Social Phenomena4

Informed Consent Truth Disclosure Personal Autonomy Disclosure

Humanities3

Ethics, Medical Personal Autonomy Ethics, Research

Information Science4

Survival Rate Questionnaires Disclosure Radiotherapy, Conformal

Named Groups1

Research Subjects

Health Care39

Clinical Trials, Phase I as Topic Clinical Trials as Topic Treatment Outcome Area Under Curve Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Feasibility Studies Patient Selection Double-Blind Method Follow-Up Studies Informed Consent Survival Analysis Safety Survival Rate Multicenter Studies as Topic Disease-Free Survival Cohort Studies Pilot Projects Controlled Clinical Trials as Topic Prospective Studies Ethics, Medical Clinical Protocols Risk Assessment Patient Participation Personal Autonomy Questionnaires Dose-Response Relationship, Radiation Clinical Trials Data Monitoring Committees Single-Blind Method Treatment Failure Early Termination of Clinical Trials Sample Size Kaplan-Meier Estimate Vaccination Retrospective Studies Karnofsky Performance Status Risk Factors Ethics, Research Severity of Illness Index

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials, Phase I as Topic Maximum Tolerated Dose Drug Evaluation Neoplasms Drug Administration Schedule Conduct Disorder Clinical Trials as Topic Infusions, Intravenous Antineoplastic Agents Dose-Response Relationship, Drug Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Nontherapeutic Human Experimentation Area Under Curve Nausea Administration, Oral Research Design Paclitaxel Clinical Trials, Phase II as Topic Deoxycytidine Neutropenia Combined Modality Therapy Thrombocytopenia Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Vomiting Carboplatin Hematologic Diseases Fluorouracil Antibodies, Monoclonal Metabolic Clearance Rate Camptothecin Dacarbazine Taxoids Clinical Trials, Phase III as Topic Time Factors Leukopenia Feasibility Studies Patient Selection Double-Blind Method Lung Neoplasms Cisplatin Topotecan Stomatitis Melanoma Fatigue Quinazolines Injections, Subcutaneous Follow-Up Studies Cancer Vaccines Half-Life Informed Consent Neoplasm Staging Neoplasm Metastasis Neoplasm Recurrence, Local Immunotoxins Infusions, Parenteral Brain Stem Neoplasms Drugs, Investigational Radioimmunotherapy Ovarian Neoplasms Recombinant Proteins Therapeutic Human Experimentation Doxorubicin Survival Analysis Benzenesulfonates Carcinoma, Non-Small-Cell Lung Pyrazines Research Subjects Kidney Neoplasms Antineoplastic Agents, Alkylating Boronic Acids Organoplatinum Compounds Safety Brain Neoplasms Coxiella Survival Rate Injections, Intravenous Placebos Phenylurea Compounds Farnesyltranstransferase Metabolic Detoxication, Phase I Multicenter Studies as Topic Drug-Related Side Effects and Adverse Reactions Medical Oncology Epothilones Drug Therapy, Combination Pyridines Disease-Free Survival Carcinoma, Renal Cell Recurrence Niacinamide Peritoneal Neoplasms Glioma Radiotherapy Dosage Dose Fractionation Breast Neoplasms Yttrium Radioisotopes Aziridines Exanthema

No FAQ available that match "conduct of phase i trials"